Market Cap 992.81M
Revenue (ttm) 348.88M
Net Income (ttm) 42.42M
EPS (ttm) N/A
PE Ratio 22.77
Forward PE 23.97
Profit Margin 12.16%
Debt to Equity Ratio 0.01
Volume 1,322,800
Avg Vol 656,052
Day's Range N/A - N/A
Shares Out 147.96M
Stochastic %K 94%
Beta 1.73
Analysts Strong Sell
Price Target $12.20

Company Profile

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techni...

Industry: Biotechnology
Sector: Healthcare
Phone: 770 651 9100
Address:
1775 West Oak Commons Court, NE, Marietta, United States
SweepCastApp
SweepCastApp Oct. 3 at 3:10 PM
$MDXG: Unusual Options Activity Alerted CALL flow observed 390x contracts at Strike price of $7.5 Exp on 12/19/2025 with Premium of $36K and showing BEARISH Sentiment
0 · Reply
biomaster22
biomaster22 Oct. 3 at 12:25 AM
$MDXG absolute pos crapper is worthless CEO
0 · Reply
highnihilism
highnihilism Oct. 1 at 7:45 AM
$GSM Ferroglobe Trade Count: 18 | Total $: 6.8 K | 0.23 × 90-Day Avg $: 29.1 K | Call $: 6.9 K | Put $: 15 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $WD Walker & Dunlop Trade Count: 19 | Total $: 32 K | 3.37 × 90-Day Avg $: 9.5 K | Call $: 6.8 K | Put $: 25.2 K | % Single-Leg: 3% | % Multi-Leg: 97% | % Contingent: – $ITRN Ituran Location & Control Trade Count: 13 | Total $: 11.9 K | 1.93 × 90-Day Avg $: 6.2 K | Call $: 6.8 K | Put $: 5.1 K | % Single-Leg: 30% | % Multi-Leg: 70% | % Contingent: – $MDXG Mimedx Group Trade Count: 17 | Total $: 8.6 K | 0.61 × 90-Day Avg $: 14.1 K | Call $: 6.8 K | Put $: 1.8 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
GlobalInsights
GlobalInsights Sep. 30 at 2:42 PM
$MDXG Comment period closed on Sept 13? https://govhealth.distilinfo.com/2025/07/17/cms-announces-fixed-price-skin/
0 · Reply
GlobalInsights
GlobalInsights Sep. 29 at 3:11 PM
$MDXG https://www.linkedin.com/posts/snelson_wounddressings-chronicwounds-medtech-activity-7378395896297836544-qQGD?utm_medium=ios_app&rcm=ACoAAAxiyWcBcBA3mY2FkMSqI5cP8qMztSn0mfA&utm_source=social_share_video_v2&utm_campaign=copy_link
0 · Reply
Monticello4
Monticello4 Sep. 29 at 10:51 AM
$MDXG Remember this post? FinancialScience - May 28, 2025 12:01 AM $MDXG any mdxg shareholder who does not swap their mdxg shares for orgo shares is a dummy Bearish Bbbbbbbbwwwwwwhahahahahahahahaha!!!!!!!!!!!
0 · Reply
CharlyBue
CharlyBue Sep. 26 at 4:11 PM
$MDXG its Friday, options play as always, SP down the road 🤮
0 · Reply
GlobalInsights
GlobalInsights Sep. 26 at 2:50 PM
$MDXG See ORGO’s 2nd KOA trial did not achieve statistical significance. Sounds familiar.
0 · Reply
njbugatti
njbugatti Sep. 25 at 10:06 PM
$MDXG so an hour ago Orgo’s RENU also announced it failed its to meet its primary endpoint of P3 OA trial. spin it how they want but they will repeat MDXG Injectible pathway (death) as well. what the heck is so difficult with OA that Im clearly missing? Hundreds of millions of research dollars dedicated to this track and ZERO!
1 · Reply
biomaster22
biomaster22 Sep. 24 at 11:48 AM
$MDXG 33 PE no wonder we cant get any movement crapper you and the bosrd should give back all your free shares you sre useless
1 · Reply
Latest News on MDXG
MIMEDX to Participate in Upcoming Investor Conferences

Aug 27, 2025, 8:00 AM EDT - 5 weeks ago

MIMEDX to Participate in Upcoming Investor Conferences


MiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 11:01 PM EDT - 2 months ago

MiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call Transcript


MIMEDX Announces Strategic Collaboration with Vaporox, Inc.

Jul 30, 2025, 8:00 AM EDT - 2 months ago

MIMEDX Announces Strategic Collaboration with Vaporox, Inc.


MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 9:52 PM EDT - 5 months ago

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript


MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

Feb 27, 2025, 8:00 AM EST - 7 months ago

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference


MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 10:50 PM EST - 7 months ago

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript


MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 9:38 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript


MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 9:10 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript


MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 9:33 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript


MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 8:46 PM EST - 1 year ago

MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript


MIMEDX to Highlight Published Data at SAWC Fall

Nov 2, 2023, 8:00 AM EDT - 2 years ago

MIMEDX to Highlight Published Data at SAWC Fall


MiMedx Group, Inc. (MDXG) Q3 2023 Earnings Call Transcript

Oct 30, 2023, 9:17 PM EDT - 2 years ago

MiMedx Group, Inc. (MDXG) Q3 2023 Earnings Call Transcript


MiMedx Group, Inc. (MDXG) Q2 2023 Earnings Call Transcript

Aug 1, 2023, 6:48 PM EDT - 2 years ago

MiMedx Group, Inc. (MDXG) Q2 2023 Earnings Call Transcript


SweepCastApp
SweepCastApp Oct. 3 at 3:10 PM
$MDXG: Unusual Options Activity Alerted CALL flow observed 390x contracts at Strike price of $7.5 Exp on 12/19/2025 with Premium of $36K and showing BEARISH Sentiment
0 · Reply
biomaster22
biomaster22 Oct. 3 at 12:25 AM
$MDXG absolute pos crapper is worthless CEO
0 · Reply
highnihilism
highnihilism Oct. 1 at 7:45 AM
$GSM Ferroglobe Trade Count: 18 | Total $: 6.8 K | 0.23 × 90-Day Avg $: 29.1 K | Call $: 6.9 K | Put $: 15 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $WD Walker & Dunlop Trade Count: 19 | Total $: 32 K | 3.37 × 90-Day Avg $: 9.5 K | Call $: 6.8 K | Put $: 25.2 K | % Single-Leg: 3% | % Multi-Leg: 97% | % Contingent: – $ITRN Ituran Location & Control Trade Count: 13 | Total $: 11.9 K | 1.93 × 90-Day Avg $: 6.2 K | Call $: 6.8 K | Put $: 5.1 K | % Single-Leg: 30% | % Multi-Leg: 70% | % Contingent: – $MDXG Mimedx Group Trade Count: 17 | Total $: 8.6 K | 0.61 × 90-Day Avg $: 14.1 K | Call $: 6.8 K | Put $: 1.8 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
GlobalInsights
GlobalInsights Sep. 30 at 2:42 PM
$MDXG Comment period closed on Sept 13? https://govhealth.distilinfo.com/2025/07/17/cms-announces-fixed-price-skin/
0 · Reply
GlobalInsights
GlobalInsights Sep. 29 at 3:11 PM
$MDXG https://www.linkedin.com/posts/snelson_wounddressings-chronicwounds-medtech-activity-7378395896297836544-qQGD?utm_medium=ios_app&rcm=ACoAAAxiyWcBcBA3mY2FkMSqI5cP8qMztSn0mfA&utm_source=social_share_video_v2&utm_campaign=copy_link
0 · Reply
Monticello4
Monticello4 Sep. 29 at 10:51 AM
$MDXG Remember this post? FinancialScience - May 28, 2025 12:01 AM $MDXG any mdxg shareholder who does not swap their mdxg shares for orgo shares is a dummy Bearish Bbbbbbbbwwwwwwhahahahahahahahaha!!!!!!!!!!!
0 · Reply
CharlyBue
CharlyBue Sep. 26 at 4:11 PM
$MDXG its Friday, options play as always, SP down the road 🤮
0 · Reply
GlobalInsights
GlobalInsights Sep. 26 at 2:50 PM
$MDXG See ORGO’s 2nd KOA trial did not achieve statistical significance. Sounds familiar.
0 · Reply
njbugatti
njbugatti Sep. 25 at 10:06 PM
$MDXG so an hour ago Orgo’s RENU also announced it failed its to meet its primary endpoint of P3 OA trial. spin it how they want but they will repeat MDXG Injectible pathway (death) as well. what the heck is so difficult with OA that Im clearly missing? Hundreds of millions of research dollars dedicated to this track and ZERO!
1 · Reply
biomaster22
biomaster22 Sep. 24 at 11:48 AM
$MDXG 33 PE no wonder we cant get any movement crapper you and the bosrd should give back all your free shares you sre useless
1 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Sep. 23 at 8:35 PM
$MDXG 7 weeks……
1 · Reply
CharlyBue
CharlyBue Sep. 23 at 8:48 AM
$MDXG target $12, that‘s an announcement - BUY 🚀 https://www.tipranks.com/news/blurbs/craig-hallum-sticks-to-their-buy-rating-for-mimedx-group-mdxg-blurbs-2
1 · Reply
GlobalInsights
GlobalInsights Sep. 19 at 7:38 PM
$MDXG Quadruple witching’s expiration today!
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Sep. 19 at 12:39 AM
$MDXG Crossed above daily 21ema. A small step in right direction. 6 weeks till CMS decision.
0 · Reply
GlobalInsights
GlobalInsights Sep. 17 at 3:51 PM
$MDXG Full report from prior jpenn post. https://oig.hhs.gov/documents/evaluation/10939/OEI-BL-24-00420.pdf
0 · Reply
jpenn876
jpenn876 Sep. 17 at 4:19 AM
$MDXG Feels like it might actually happen in January. https://oig.hhs.gov/reports/all/2025/medicare-part-b-payment-trends-for-skin-substitutes-raise-major-concerns-about-fraud-waste-and-abuse/
1 · Reply
highnihilism
highnihilism Sep. 16 at 7:51 PM
IWM: Russell 2000 → $MDXG Mimedx Group $PLYM Plymouth Industrial REIT $CADE Cadence Bank $PRTA Prothena $BLKB Blackbaud
0 · Reply
highnihilism
highnihilism Sep. 16 at 3:08 PM
Biotech → $RCUS Arcus Biosciences $DVAX Dynavax Technologies $MDXG Mimedx Group $VCYT Veracyte $RLAY Relay Therapeutics
0 · Reply
GlobalInsights
GlobalInsights Sep. 15 at 6:51 PM
$MDXG https://carolinefifemd.com/2025/09/15/skin-substitute-payment-reform/
1 · Reply
Omstapocus
Omstapocus Sep. 11 at 3:47 PM
$MDXG IMO, there is only one reason to continue to own this stock and that will be the announcement on January first relative to the LCDs. If it is favorable and effectively eliminates the majority of the competition, given the very strong balance sheet and 2026 projections, the growth will be in the greater market share opportunity for Surgical Application. That assumes that there are those at the company who are knowledgeable about surgical opportunity. We have been told that there are studies underway but there have been no updates. If any of those studies are clinically advantageous and reimbursable then there are too many mature surgical companies out there who will see benefit for acquisition. It has been more than painful to have sustained this nightmare, but, giving up now, despite any profit gained, makes little sense given the significant potential. The horses are at the gate , and you bet the fifty to one shot. And they’re off.
5 · Reply
biomaster22
biomaster22 Sep. 11 at 12:02 PM
$MDXG why is crapper even still employed since he has taken over this stock has done nothng for shareholders ? let's all sell and drive this POS to 0.00 so managment and BOD can't keep stealing our money for no return !
2 · Reply
MrStealYourShares
MrStealYourShares Sep. 10 at 3:16 PM
$MDXG Sold Dec 19 7.5 calls against my position the other day for 1.40 after closing my September covered calls for a .60 gain. Buy order for more shares at $6.
0 · Reply